00867 CMS
WatchlistCMS News
CMS: Voluntary and Business Update Announcement New Drug Application for Additional RA Indication of Methotrexate Injection Accepted in China
CMS: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
CMS: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
CMS: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023
CMS: CONTINUING CONNECTED TRANSACTIONS RELATED TO DIAZEPAM NASAL SPRAY (VALTOCO) AMENDED TERMS AND REVISED ANNUAL CAPS
CMS: Notification Letter
CMS: Interim Report 2023
CMS: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023
CMS: CONTINUING CONNECTED TRANSACTION RELATED TO DIAZEPAM NASAL SPRAY (VALTOCO)
CMS: INTERIM DIVIDEND FOR THE SIX MONTHS ENDED 30 JUNE 2023
CMS: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2023
CMS: Voluntary and Business Update Announcement Gaining Exclusive License of an Anti-Ischemic Stroke Class 1 Innovative Drug
CMS: Notice of Board Meeting
CMS: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
CMS: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023
CMS: Voluntary and Business Update Announcement New Drug Application of Diazepam Nasal Spray Approved in China
CMS: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023
CMS: Voluntary and Business Update Announcement New Drug Application of Tildrakizumab Injection Approved in China
CMS: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2023
CMS: THIRD AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION